There were increased autoantibodies in invasive breast cancer to ARPC2 (p < 0.0001 for controls, Fig. 5b) and KRT8 (p = 0.0004 for controls, Fig. 5d). This evidence concerns the gene KRT8 and invasive breast carcinoma.